Approaches which may reduce costs
associated with CINV, including economic
consequences of healthcare visits: 1,9
Educating
patients
Increasing
guideline
adherence
• Patient non-compliance to antiemetic
prophylaxis represented a problem for
42% of oncologists 11
• Simplifying regimens has been suggested
to improve patients’ adherence
to guideline-recommended CINV
prophylaxis 11
Initiated and funded by:
Improving
management of
CINV episodes
Optimising use
of CINV
prophylactic
agents
References: 1. Aapro M, et al. Ann Oncol 2012;
23:1986–1992. 2. Boccia RV. J Clin Outcomes Manag
2013; 20:377–384. 3. Ihbe-Heffinger A, et al. Ann Oncol
2004; 15:526–536. 4. Navari RM, et al. N Engl J Med
2016; 374:1356-67. 5. Sommariva S, et al. Crit Rev Oncol
Hematol 2015; 99:13–36. 6. Janelsins MC, et al. Expert Opin
Pharmacother 2013; 14(6): 757–766. 7. Rao KV, et al. Am
Health Drug Benefits 2012; 5(4): 232–240. 8. Kimberley A
and Noonan RN. 2005. Advanced Studies in Nursing. 2005;
3(1):16-21. 9. Turini M, et al. Drugs Context 2015; 4:212285.
10. Van Laar, et al. Support Care Cancer 2015; 23:151–157
11. Ruffo P, et al. ASCO 2016. Abstr e18158.
in association with: